BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In summary, BCR-ABL1 is the central player in the pathogenesis of CML, with the expression of its oncoprotein leading to clonal expansion of those hematopoietic cells, which harbor this fusion gene [18].